"mycoplasma genitalium among men with urethritis attending STD clinics in the US: assessing burden, risk factors and CO-infections"

Ended Awarded Last action

Contract number
HHSN27200010
Awardee
Awarding agency
Obligated
$1,371,585

Award facts

Contract value 60% obligated
  • $1,371,585.40 Current, with exercised options
  • $2,278,012.40 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Birmingham, AL 35233, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$298,662
Supplemental Agreement for work within scope P00006 $0
Exercise an Option P00005 $288,930
Supplemental Agreement for work within scope 4 $84,719
Supplemental Agreement for work within scope 3 $0
Supplemental Agreement for work within scope 2 $0
Other Administrative Action 1 $0
Original award $1,296,598

About this award

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to the University of Alabama at Birmingham (UAB) to study Mycoplasma genitalium infections among men with urethritis attending STD clinics in the U.S. The $2,278,012.40 contract has a period of performance through August 31, 2019 and does not have a set-aside designation. UAB is the prime contractor, with several universities serving as subcontractors, including the University of Pittsburgh, Louisiana State University Health Sciences Center New Orleans, the University of North Carolina at Chapel Hill, and Wake Forest University. The contract aims to assess the burden, risk factors, and co-infections associated with Mycoplasma genitalium in this population, reflecting NIAID's broader mission to research and address infectious diseases.

Quick answers

Who was awarded contract HHSN27200010?

HHSN27200010 was awarded to University Of Alabama At Birmingham by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 21, 2016.

How much is contract HHSN27200010 worth?

The government has obligated $1,371,585 on HHSN27200010. Its potential value, with all options, is $2,278,012.

Is contract HHSN27200010 an order under another contract?

Yes. HHSN27200010 is a delivery order under HHSN272201300012I, an indefinite delivery contract.

Was contract HHSN27200010 competed?

The extent of competition for HHSN27200010 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award